This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Journalology/ Peer Review/ Authorship  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

A Statement From the International Committee of Medical Journal Editors

Catherine D. DeAngelis, MD, MPH; Jeffrey M. Drazen, MD; Frank A. Frizelle, MB, ChB, MMedSc, FRACS; Charlotte Haug, MD, PhD, MSc; John Hoey, MD; Richard Horton, FRCP; Sheldon Kotzin, MLS; Christine Laine, MD, MPH; Ana Marusic, MD, PhD; A. John P.M. Overbeke, MD, PhD; Torben V. Schroeder, MD, DMSc; Hal C. Sox, MD; Martin B. Van Der Weyden, MD

JAMA. 2005;293:2927-2929. Published online May 23, 2005 (doi:10.1001/jama.293.23.jed50037)

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In September 2004, the members of the International Committee of Medical Journal Editors (ICMJE) published a joint editorial aimed at promoting registration of all clinical trials.¹ We stated that we will consider a trial for publication only if it has been registered before the enrollment of the first patient. This policy applies to trials that start recruiting on or after July 1, 2005. Because many ongoing trials were not registered at inception, we will consider for publication ongoing trials that are registered before September 13, 2005. Our goal then and now . . . [Full Text of this Article]

Author Affiliations: Dr DeAngelis is editor-in-chief, JAMA; Dr Drazen is editor-in-chief, New England Journal of Medicine; Prof Fizelle is editor, The New Zealand Medical Journal; Dr Haug is editor-in-chief, Norwegian Medical Journal; Dr Hoey is editor, CMAJ; Dr Horton is editor, The Lancet; Mr Kotzin is executive editor, MEDLINE, National Library of Medicine; Dr Laine is senior deputy editor, Annals of Internal Medicine; Dr Marusic is editor, Croatian Medical Journal; Dr Overbeke is executive editor, Nederlands Tijdschrift voor Geneeskunde (Dutch Journal of Medicine); Dr Schroder is editor, Journal of the Danish Medical Association; Dr Sox is editor, Annals of Internal Medicine; and Dr Van Der Weyden is editor, The Medical Journal of Australia.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Trials Design Lessons From the CATIE Study
Kraemer et al.
Am. J. Psychiatry 2009;166:1222-1228.
ABSTRACT | FULL TEXT  

Bidirectional Conflicts of Interest Involving Industry and Medical Journals: Who Will Champion Integrity?
Lanier
Mayo Clin Proc. 2009;84:771-775.
FULL TEXT  

Registration of trials in children: update of current international initiatives
Pandolfini et al.
Arch. Dis. Child. 2009;94:717-719.
FULL TEXT  

Publication of Clinical Trials
Swiontkowski
JBJS 2009;91:1-2.
FULL TEXT  

A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005
Rowan-Legg et al.
J. Med. Ethics 2009;35:74-78.
ABSTRACT | FULL TEXT  

Tracing Biological Collections: Between Books and Clinical Trials
Kauffmann and Cambon-Thomsen
JAMA 2008;299:2316-2318.
FULL TEXT  

Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Litigation
Psaty and Kronmal
JAMA 2008;299:1813-1817.
ABSTRACT | FULL TEXT  

Variations Between Clinical Trial Participants and Medicare Beneficiaries in Evidence Used for Medicare National Coverage Decisions
Dhruva and Redberg
Arch Intern Med 2008;168:136-140.
ABSTRACT | FULL TEXT  

Publication of Clinical Trials in JAMA: Information for Authors
Fontanarosa and DeAngelis
JAMA 2008;299:95-96.
FULL TEXT  

The role of a Prospective Public Health Intervention Study Register in building public health evidence: proposal for content and use
Waters et al.
J Public Health (Oxf) 2007;29:322-327.
ABSTRACT | FULL TEXT  

Institutional Review Boards Should Require Clinical Trial Registration
Levin and Palmer
Arch Intern Med 2007;167:1576-1580.
FULL TEXT  

Issues in the Registration of Clinical Trials
Zarin et al.
JAMA 2007;297:2112-2120.
ABSTRACT | FULL TEXT  

High-Deductible Health Plans and Emergency Department Use
Grudzen and Brook
JAMA 2007;297:1126-1127.
FULL TEXT  

Association Between Unreported Outcomes and Effect Size Estimates in Cochrane Meta-analyses
Furukawa et al.
JAMA 2007;297:468-470.
FULL TEXT  

Clinical Trial Investigators and Their Prescribing Patterns: Another Dimension to the Relationship Between Physician Investigators and the Pharmaceutical Industry
Psaty and Rennie
JAMA 2006;295:2787-2790.
FULL TEXT  

Instructions for Authors
JAMA 2006;295:103-111.
FULL TEXT  

Academic Medical Centers and Medical Research: The Challenges Ahead
Cohen and Siegel
JAMA 2005;294:1367-1372.
ABSTRACT | FULL TEXT  

Consensus and Controversy in Clinical Research Ethics
Brody et al.
JAMA 2005;294:1411-1414.
FULL TEXT  

Registration of Clinical Trials
Levin et al.
Arch Ophthalmol 2005;123:1263-1264.
FULL TEXT  

Optimizing the Science of Quality Improvement
Peterson
JAMA 2005;294:369-371.
FULL TEXT  

Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies
Fontanarosa et al.
JAMA 2005;294:110-111.
FULL TEXT  

Instructions for Authors
JAMA 2005;294:119-127.
FULL TEXT